FDA Expands Use of Remdesivir for COVID-19 Treatment The Federal Drug Administration has broadened its emergency use authorization for the anti-viral drug remdesivir to include all hospitalized coronavirus patients, not just those who are so ill they require ventilators or oxygen therapy.
|
